1: Singh S, Samineni R, Pabbaraja S, Mehta G. A General Carbazole Synthesis via Stitching of Indole-Ynones with Nitromethanes: Application to Total Synthesis of Carbazomycin A, Calothrixin B, and Staurosporinone. Org Lett. 2019 May 3;21(9):3372-3376. doi: 10.1021/acs.orglett.9b01111. Epub 2019 Apr 23. PMID: 31013110.
2: Fox JC, Gilligan RE, Pitts AK, Bennett HR, Gaunt MJ. The total synthesis of K-252c (staurosporinone) via a sequential C-H functionalisation strategy. Chem Sci. 2016 Apr 21;7(4):2706-2710. doi: 10.1039/c5sc04399a. Epub 2016 Jan 21. PMID: 28660044; PMCID: PMC5477024.
3: Kaneko M, Saito Y, Saito H, Matsumoto T, Matsuda Y, Vaught JL, Dionne CA, Angeles TS, Glicksman MA, Neff NT, Rotella DP, Kauer JC, Mallamo JP, Hudkins RL, Murakata C. Neurotrophic 3,9-bis[(alkylthio)methyl]-and-bis(alkoxymethyl)-K-252a derivatives. J Med Chem. 1997 Jun 6;40(12):1863-9. doi: 10.1021/jm970031d. PMID: 9191963.
4: Peruzzi B, Bottaro DP. Targeting the c-Met signaling pathway in cancer. Clin Cancer Res. 2006 Jun 15;12(12):3657-60. doi: 10.1158/1078-0432.CCR-06-0818. PMID: 16778093.
5: Wada Y, Nagasaki H, Tokuda M, Orito K. Synthesis of N-protected staurosporinones. J Org Chem. 2007 Mar 16;72(6):2008-14. doi: 10.1021/jo062184r. Epub 2007 Feb 20. PMID: 17309305.
6: Oga S, Goto K, Sakamoto J, Honda Y, Sasaki R, Ishikawa K, Kataoka H, Nakano J, Origuchi T, Okita M. Mechanisms underlying immobilization-induced muscle pain in rats. Muscle Nerve. 2020 May;61(5):662-670. doi: 10.1002/mus.26840. Epub 2020 Mar 8. PMID: 32083755.
7: Tamaki K, Shotwell JB, White RD, Drutu I, Petsch DT, Nheu TV, He H, Hirokawa Y, Maruta H, Wood JL. Efficient syntheses of novel C2'-alkylated (+/-)-K252a analogues. Org Lett. 2001 May 31;3(11):1689-92. doi: 10.1021/ol015894m. PMID: 11405687.
8: Zhang GY, Zhang QG. Agents targeting c-Jun N-terminal kinase pathway as potential neuroprotectants. Expert Opin Investig Drugs. 2005 Nov;14(11):1373-83. doi: 10.1517/13543784.14.11.1373. PMID: 16255677.
9: Rüegg UT, Burgess GM. Staurosporine, K-252 and UCN-01: potent but nonspecific inhibitors of protein kinases. Trends Pharmacol Sci. 1989 Jun;10(6):218-20. doi: 10.1016/0165-6147(89)90263-0. PMID: 2672462.
10: Mahboobi S, Eibler E, Koller M, Kumar KC S, Popp A, Schollmeyer D. Synthesis of Pyrrolidin-2-ones and of Staurosporine Aglycon (K-252c) by Intermolecular Michael Reaction. J Org Chem. 1999 Jun 25;64(13):4697-4704. doi: 10.1021/jo9825106. PMID: 11674542.
11: Lazarovici P, Rasouly D, Friedman L, Tabekman R, Ovadia H, Matsuda Y. K252a and staurosporine microbial alkaloid toxins as prototype of neurotropic drugs. Adv Exp Med Biol. 1996;391:367-77. doi: 10.1007/978-1-4613-0361-9_31. PMID: 8726076.
12: Liu X, Ye K, Weinshenker D. Norepinephrine Protects against Amyloid-β Toxicity via TrkB. J Alzheimers Dis. 2015;44(1):251-60. doi: 10.3233/JAD-141062. PMID: 25208620; PMCID: PMC4714587.
13: Knüsel B, Hefti F. K-252 compounds: modulators of neurotrophin signal transduction. J Neurochem. 1992 Dec;59(6):1987-96. doi: 10.1111/j.1471-4159.1992.tb10085.x. PMID: 1431889.
14: Tran TD, Cartner LK, Bokesch HR, Henrich CJ, Wang XW, Mahidol C, Ruchirawat S, Kittakoop P, O'Keefe BR, Gustafson KR. NMR characterization of rearranged staurosporine aglycone analogues from the marine sponge Damiria sp. Magn Reson Chem. 2021 May;59(5):534-539. doi: 10.1002/mrc.4932. Epub 2019 Sep 9. PMID: 31379005; PMCID: PMC7428849.
15: Nick TA, Ribera AB. Synaptic activity modulates presynaptic excitability. Nat Neurosci. 2000 Feb;3(2):142-9. doi: 10.1038/72082. PMID: 10649569.
16: Dankwa S, Dols MM, Wei L, Glennon EKK, Kain HS, Kaushansky A, Smith JD. Exploiting polypharmacology to dissect host kinases and kinase inhibitors that modulate endothelial barrier integrity. Cell Chem Biol. 2021 Dec 16;28(12):1679-1692.e4. doi: 10.1016/j.chembiol.2021.06.004. Epub 2021 Jul 2. PMID: 34216546; PMCID: PMC8688180.
17: Kafitz KW, Rose CR, Thoenen H, Konnerth A. Neurotrophin-evoked rapid excitation through TrkB receptors. Nature. 1999 Oct 28;401(6756):918-21. doi: 10.1038/44847. PMID: 10553907.
18: Cherubini E, Mariotta S, Scozzi D, Mancini R, Osman G, D'Ascanio M, Bruno P, Cardillo G, Ricci A. BDNF/TrkB axis activation promotes epithelial-mesenchymal transition in idiopathic pulmonary fibrosis. J Transl Med. 2017 Sep 22;15(1):196. doi: 10.1186/s12967-017-1298-1. PMID: 28938915; PMCID: PMC5610541.
19: Oyama Y, Nagao S, Na L, Yanai K, Umebayashi M, Nakamura K, Nagai S, Fujimura A, Yamasaki A, Nakayama K, Morisaki T, Onishi H. TrkB/BDNF Signaling Could Be a New Therapeutic Target for Pancreatic Cancer. Anticancer Res. 2021 Aug;41(8):4047-4052. doi: 10.21873/anticanres.15205. PMID: 34281873.
20: Diniz CRAF, da Silva LA, Domingos LB, Sonego AB, Moraes LRB, Joca S. Fluoxetine acts concomitantly on dorsal and ventral hippocampus to Trk- dependently modulate the extinction of fear memory. Prog Neuropsychopharmacol Biol Psychiatry. 2022 Mar 8;113:110451. doi: 10.1016/j.pnpbp.2021.110451. Epub 2021 Oct 4. PMID: 34619303.